Effect of Toxicants on Oocyte Quality and Embryo Development
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Toxicogenomics".
Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 10800
Special Issue Editor
Interests: toxicants; oocyte quality; embryo development; gene expression; molecular mechanisms
Special Issue Information
Dear Colleagues,
Oocyte competence is a determinant in attaining viable zygotes, which is fundamental for correct preimplantation embryonic development and is ultimately responsible for achieving a viable pregnancy. Man-made chemicals and drugs for therapeutic and/or recreational use can significantly affect the correct maturation of an oocyte and irreversibly compromise the early stages of embryonic development, significantly decreasing the chances of attaining a potential offspring by impacting the genomic and epigenetic profiles of gametes and embryos at specific key stages of maturation/development. Correct and timely genomic and transcriptional activation during oocyte maturation and embryo development is crucial to attaining a viable pregnancy. Understanding the genomic and epigenetic mechanisms of action of toxicants, such as endocrine disrupting compounds, during early development is a necessary step to fully comprehend their possible impact on fertility, leading to further regulation of the use of man-made chemicals and drugs—such as pesticides, plasticizers and unregulated substances, in women of reproductive age as well as in farm animals—that have been shown to be more sensitive to the exposure to such persistent and spread toxicants in the environment.
This Special Issue aims to present a collection of articles showcasing novel and international research in the field of reproductive toxicology, spanning from the direct genomic, genetic and epigenetic effects of toxicants on gametes, on preimplantation embryo stages of development and on the follicular environment responsible for oocyte competence and, ultimately, on achieving a viable pregnancy.
Manuscripts on the following topics are encouraged and will be considered for publication: toxicant effects at the genomic and epigenetic levels in gametes and early embryo; effects of endocrine disrupting compounds on oocyte competence and embryo development; effects of recreational and therapeutic drugs on fertility and early development; effects of man-made and natural chemicals on gene expression, genomic activation, transcriptome profile and epigenetic modifications in gametes, embryos and reproductive tissues; effects of oxidative and/or heat stress during development; and mechanistic articles on the genomic function of toxicants during early development.
Dr. Laura A. Favetta
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- endocrine disrupting compounds
- recreational and therapeutic drugs
- genomic and epigenetic modifications
- transcriptome
- gene expression
- maternal embryonic transition
- oxidative stress
- preimplantation embryonic development
- oocyte competence
- oocyte maturation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.